Lipid-protein interactions in GPCR-associated signaling

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 4, 2007, Pages 836-852

  Escribá, Pablo V ^a   Wedegaertner, Philip B ^b   Goñi, Félix M ^c   Vögler, Oliver ^a  

^a Institut Universitari d'Investigacio en Ciencies de la Salut IUNICS   (Spain)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Farnesyl; G protein; G protein coupled receptor; Geranylgeraniol; Isoprenylation; Membrane structure; Myristoylation; Palmitoylation; Phospholipase C; Protein kinase C; Signal transduction

Indexed keywords

G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE LIPID; PHOSPHOLIPASE C; PROTEIN KINASE C;

CELL MEMBRANE; HUMAN; ISOPRENYLATION; MEMBRANE BINDING; MEMBRANE STRUCTURE; MYRISTYLATION; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

CELL MEMBRANE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MEMBRANE LIPIDS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 33947431049     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.09.001     Document Type: Review

References (208)

1. Stevens T.J., and Arkin I.T. Do more complex organisms have a greater proportion of membrane proteins in their genomes?. Proteins 39 (2000) 417-420
2. Daemen F.J., and Bonting S.L. Transient light-induced conformational changes in rhodopsin. Biophys. Struct. Mech. 3 (1977) 117-120
3. Gether U., Lin S., Ghanouni P., Ballesteros J.A., Weinstein H., and Kobilka B.K. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J. 16 (1997) 6737-6747
4. Halliday K.R., Stein P.J., Chernoff N., Wheeler G.L., and Bitensky M.W. Limited trypsin proteolysis of photoreceptor GTP-binding protein. Light- and GTP-induced conformational changes. J. Biol. Chem. 259 (1984) 516-525
5. Hayer-Hartl M., Schagger H., von Jagow G., and Beyer K. Interactions of phospholipids with the mitochondrial cytochrome-c reductase studied by spin-label ESR and NMR spectroscopy. Eur. J. Biochem. 209 (1992) 423-430
6. Dowhan W. Molecular basis for membrane phospholipid diversity: why are there so many lipids?. Annu. Rev. Biochem. 66 (1997) 199-232
7. O'Brien P.J., and Zatz M. Acylation of bovine rhodopsin by [3H]palmitic acid. J. Biol. Chem. 259 (1984) 5054-5057
8. Buss J.E., Mumby S.M., Casey P.J., Gilman A.G., and Sefton B.M. Myristoylated alpha subunits of guanine nucleotide-binding regulatory proteins. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7493-7497
9. Sugars J.M., Cellek S., Manifava M., Coadwell J., and Ktistakis N.T. Fatty acylation of phospholipase D1 on cysteine residues 240 and 241 determines localization on intracellular membranes. J. Biol. Chem. 274 (1999) 30023-30027
10. Stoffel R.H., Randall R.R., Premont R.T., Lefkowitz R.J., and Inglese J. Palmitoylation of G protein-coupled receptor kinase, GRK6. Lipid modification diversity in the GRK family. J. Biol. Chem. 269 (1994) 27791-27794
11. Brown D.A., and London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14 (1998) 111-136
12. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev., Mol. Cell Biol. 1 (2000) 31-39
13. Rowat A.C., Brask J., Sparrman T., Jensen K.J., Lindblom G., and Ipsen J.H. Farnesylated peptides in model membranes: a biophysical investigation. Eur. Biophys. J. 33 (2004) 300-309
14. Janosch S., Nicolini C., Ludolph B., Peters C., Volkert M., Hazlet T.L., Gratton E., Waldmann H., and Winter R. Partitioning of dual-lipidated peptides into membrane microdomains: lipid sorting vs peptide aggregation. J. Am. Chem. Soc. 126 (2004) 7496-7503
15. Takeda S., Kadowaki S., Haga T., Takaesu H., and Mitaku S. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett. 520 (2002) 97-101
16. Probst W.C., Snyder L.A., Schuster D.I., Brosius J., and Sealfon S.C. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 11 (1992) 1-20
17. Moench S.J., Moreland J., Stewart D.H., and Dewey T.G. Fluorescence studies of the location and membrane accessibility of the palmitoylation sites of rhodopsin. Biochemistry 33 (1994) 5791-5796
18. O'Dowd B.F., Hnatowich M., Caron M.G., Lefkowitz R.J., and Bouvier M. Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J. Biol. Chem. 264 (1989) 7564-7569
19. Chen C., Shahabi V., Xu W., and Liu-Chen L.Y. Palmitoylation of the rat mu opioid receptor. FEBS Lett. 441 (1998) 148-152
20. Hawtin S.R., Tobin A.B., Patel S., and Wheatley M. Palmitoylation of the vasopressin V1a receptor reveals different conformational requirements for signaling, agonist-induced receptor phosphorylation, and sequestration. J. Biol. Chem. 276 (2001) 38139-38146
21. Miggin S.M., Lawler O.A., and Kinsella B.T. Investigation of a functional requirement for isoprenylation by the human prostacyclin receptor. Eur J Biochem. 269 (2002) 1714-1725
22. Miggin S.M., Lawler O.A., and Kinsella B.T. Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation. J. Biol. Chem. 278 (2003) 6947-6958
23. Hancock J.F., Magee A.I., Childs J.E., and Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57 (1989) 1167-1177
24. Adamson P., Marshall C.J., Hall A., and Tilbrook P.A. Post-translational modifications of p21rho proteins. J. Biol. Chem. 267 (1992) 20033-20038
25. Dunphy J.T., and Linder M.E. Signalling functions of protein palmitoylation. Biochim. Biophys. Acta 1436 (1998) 245-261
26. Das A.K., Dasgupta B., Bhattacharya R., and Basu J. Purification and biochemical characterization of a protein-palmitoyl acyltransferase from human erythrocytes. J. Biol. Chem. 272 (1997) 11021-11025
27. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451 (1999) 1-16
28. Degtyarev M.Y., Spiegel A.M., and Jones T.L. Increased palmitoylation of the Gs protein alpha subunit after activation by the beta-adrenergic receptor or cholera toxin. J. Biol. Chem. 268 (1993) 23769-23772
29. Loisel T.P., Adam L., Hebert T.E., and Bouvier M. Agonist stimulation increases the turnover rate of beta 2AR-bound palmitate and promotes receptor depalmitoylation. Biochemistry 35 (1996) 15923-15932
30. El-Husseini Ael D., Schnell E., Dakoji S., Sweeney N., Zhou Q., Prange O., Gauthier-Campbell C., Aguilera-Moreno A., Nicoll R.A., and Bredt D.S. Synaptic strength regulated by palmitate cycling on PSD-95. Cell 108 (2002) 849-863
31. Parat M.O., and Fox P.L. Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. J. Biol. Chem. 276 (2001) 15776-15782
32. Omary M.B., and Trowbridge I.S. Covalent binding of fatty acid to the transferrin receptor in cultured human cells. J. Biol. Chem. 256 (1981) 4715-4718
33. Berger M., and Schmidt M.F. Protein fatty acyltransferase is located in the rough endoplasmic reticulum. FEBS Lett. 187 (1985) 289-294
34. Bonatti S., Migliaccio G., and Simons K. Palmitoylation of viral membrane glycoproteins takes place after exit from the endoplasmic reticulum. J. Biol. Chem. 264 (1989) 12590-12595
35. Drisdel R.C., Manzana E., and Green W.N. The role of palmitoylation in functional expression of nicotinic alpha7 receptors. J. Neurosci. 24 (2004) 10502-10510
36. Petaja-Repo U.E., Hogue M., Leskela T.T., Markkanen P.M., Tuusa J.T., and Bouvier M. Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor. J. Biol. Chem. 281 (2006) 15780-15789
37. Karnik S.S., Ridge K.D., Bhattacharya S., and Khorana H.G. Palmitoylation of bovine opsin and its cysteine mutants in COS cells. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 40-44
38. Zhu H., Wang H., and Ascoli M. The lutropin/choriogonadotropin receptor is palmitoylated at intracellular cysteine residues. Mol. Endocrinol. 9 (1995) 141-150
39. Fukushima Y., Saitoh T., Anai M., Ogihara T., Inukai K., Funaki M., Sakoda H., Onishi Y., Ono H., Fujishiro M., Ishikawa T., Takata K., Nagai R., Omata M., and Asano T. Palmitoylation of the canine histamine H2 receptor occurs at Cys(305) and is important for cell surface targeting. Biochim. Biophys. Acta 1539 (2001) 181-191
40. Percherancier Y., Planchenault T., Valenzuela-Fernandez A., Virelizier J.L., Arenzana-Seisdedos F., and Bachelerie F. Palmitoylation-dependent control of degradation, life span, and membrane expression of the CCR5 receptor. J. Biol. Chem. 276 (2001) 31936-31944
41. Schulein R., Liebenhoff U., Muller H., Birnbaumer M., and Rosenthal W. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. Biochem. J. 313 Pt 2 (1996) 611-616
42. Sadeghi H.M., Innamorati G., Esqueda E., and Birnbaumer M. Processing and ligand-induced modifications of the V2 vasopressin receptor. Adv. Exp. Med. Biol. 449 (1998) 339-346
43. Magee A.I., Gutierrez L., McKay I.A., Marshall C.J., and Hall A. Dynamic fatty acylation of p21N-ras. EMBO J. 6 (1987) 3353-3357
44. Skene J.H., and Virag I. Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43. J. Cell Biol. 108 (1989) 613-624
45. Mumby S.M. Reversible palmitoylation of signaling proteins. Curr Opin. Cell Biol. 9 (1997) 148-154
46. James G., and Olson E.N. Identification of a novel fatty acylated protein that partitions between the plasma membrane and cytosol and is deacylated in response to serum and growth factor stimulation. J. Biol. Chem. 264 (1989) 20998-21006
47. Mouillac B., Caron M., Bonin H., Dennis M., and Bouvier M. Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. J. Biol. Chem. 267 (1992) 21733-21737
48. Kennedy M.E., and Limbird L.E. Palmitoylation of the alpha 2A-adrenergic receptor. Analysis of the sequence requirements for and the dynamic properties of alpha 2A-adrenergic receptor palmitoylation. J. Biol. Chem. 269 (1994) 31915-31922
49. Ng G.Y., Mouillac B., George S.R., Caron M., Dennis M., Bouvier M., and O'Dowd B.F. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur. J. Pharmacol. 267 (1994) 7-19
50. Hayashi M.K., and Haga T. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. Arch. Biochem. Biophys. 340 (1997) 376-382
51. Ponimaskin E.G., Schmidt M.F., Heine M., Bickmeyer U., and Richter D.W. 5-Hydroxytryptamine 4(a) receptor expressed in Sf9 cells is palmitoylated in an agonist-dependent manner. Biochem. J. 353 (2001) 627-634
52. Kennedy M.E., and Limbird L.E. Mutations of the alpha 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling. J. Biol. Chem. 268 (1993) 8003-8011
53. Okamoto Y., Ninomiya H., Tanioka M., Sakamoto A., Miwa S., and Masaki T. Palmitoylation of human endothelinB. Its critical role in G protein coupling and a differential requirement for the cytoplasmic tail by G protein subtypes. J. Biol. Chem. 272 (1997) 21589-21596
54. Moffett S., Mouillac B., Bonin H., and Bouvier M. Altered phosphorylation and desensitization patterns of a human beta 2-adrenergic receptor lacking the palmitoylated Cys341. EMBO J. 12 (1993) 349-356
55. Wang Z., Wen X.H., Ablonczy Z., Crouch R.K., Makino C.L., and Lem J. Enhanced shutoff of phototransduction in transgenic mice expressing palmitoylation-deficient rhodopsin. J. Biol. Chem. 280 (2005) 24293-24300
56. Ponimaskin E., Dumuis A., Gaven F., Barthet G., Heine M., Glebov K., Richter D.W., and Oppermann M. Palmitoylation of the 5-hydroxytryptamine4a receptor regulates receptor phosphorylation, desensitization, and beta-arrestin-mediated endocytosis. Mol. Pharmacol. 67 (2005) 1434-1443
57. Munshi U.M., Clouser C.L., Peegel H., and Menon K.M. Evidence that palmitoylation of carboxyl terminus cysteine residues of the human luteinizing hormone receptor regulates postendocytic processing. Mol. Endocrinol. 19 (2005) 749-758
58. Gao Z., Ni Y., Szabo G., and Linden J. Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors. Biochem. J. 342 Pt 2 (1999) 387-395
59. Chen C.A., and Manning D.R. Regulation of G proteins by covalent modification. Oncogene 20 (2001) 1643-1652
60. Wedegaertner P.B. Lipid modifications and membrane targeting of G alpha. Biol. Signals Recept. 7 (1998) 125-135
61. Farazi T.A., Waksman G., and Gordon J.I. The biology and enzymology of protein N-myristoylation. J. Biol. Chem. 276 (2001) 39501-39504
62. Kokame K., Fukada Y., Yoshizawa T., Takao T., and Shimonishi Y. Lipid modification at the N terminus of photoreceptor G-protein alpha-subunit. Nature 359 (1992) 749-752
63. Neubert T.A., Johnson R.S., Hurley J.B., and Walsh K.A. The rod transducin alpha subunit amino terminus is heterogeneously fatty acylated. J. Biol. Chem. 267 (1992) 18274-18277
64. Mitchell D.A., Vasudevan A., Linder M.E., and Deschenes R.J. Protein palmitoylation by a family of DHHC protein S-acyltransferases. J Lipid Res. 47 (2006) 1118-1127
65. Kleuss C., and Krause E. Galpha(s) is palmitoylated at the N-terminal glycine. EMBO J. 22 (2003) 826-832
66. Wedegaertner P. Reversible palmitoylation in G-protein signaling. In: Bradshaw R.A., and E.A. D. (Eds). Handbook of Cell Signaling (2003), Elsevier Science, USA
67. Wedegaertner P.B., Bourne H.R., and von Zastrow M. Activation-induced subcellular redistribution of Gs alpha. Mol. Biol. Cell 7 (1996) 1225-1233
68. Yu J.Z., and Rasenick M.M. Real-time visualization of a fluorescent G(alpha)(s): dissociation of the activated G protein from plasma membrane. Mol. Pharmacol. 61 (2002) 352-359
69. Hynes T.R., Mervine S.M., Yost E.A., Sabo J.L., and Berlot C.H. Live cell imaging of Gs and the beta2-adrenergic receptor demonstrates that both alphas and beta1gamma7 internalize upon stimulation and exhibit similar trafficking patterns that differ from that of the beta2-adrenergic receptor. J. Biol. Chem. 279 (2004) 44101-44112
70. Allen J.A., Yu J.Z., Donati R.J., and Rasenick M.M. Beta-adrenergic receptor stimulation promotes G alpha s internalization through lipid rafts: a study in living cells. Mol. Pharmacol. 67 (2005) 1493-1504
71. Higgins J.B., and Casey P.J. The role of prenylation in G-protein assembly and function. Cell. Signal. 8 (1996) 433-437
72. Wright L.P., and Philips M.R. Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J. Lipid Res. 47 (2006) 883-891
73. Preininger A.M., Van Eps N., Yu N.J., Medkova M., Hubbell W.L., and Hamm H.E. The myristoylated amino terminus of Galpha(i)(1) plays a critical role in the structure and function of Galpha(i)(1) subunits in solution. Biochemistry 42 (2003) 7931-7941
74. Lukov G.L., Myung C.S., McIntire W.E., Shao J., Zimmerman S.S., Garrison J.C., and Willardson B.M. Role of the isoprenyl pocket of the G protein beta gamma subunit complex in the binding of phosducin and phosducin-like protein. Biochemistry 43 (2004) 5651-5660
75. Michaelson D., Ahearn I., Bergo M., Young S., and Philips M. Membrane trafficking of heterotrimeric G proteins via the endoplasmic reticulum and Golgi. Mol. Biol. Cell 13 (2002) 3294-3302
76. Takida S., and Wedegaertner P.B. Heterotrimer formation, together with isoprenylation, is required for plasma membrane targeting of Gbetagamma. J. Biol. Chem. 278 (2003) 17284-17290
77. Takida S., and Wedegaertner P.B. Exocytic pathway-independent plasma membrane targeting of heterotrimeric G proteins. FEBS Lett. 567 (2004) 209-213
78. Plowman S.J., and Hancock J.F. Ras signaling from plasma membrane and endomembrane microdomains. Biochim. Biophys. Acta 1746 (2005) 274-283
79. Evanko D.S., Thiyagarajan M.M., and Wedegaertner P.B. Interaction with Gbetagamma is required for membrane targeting and palmitoylation of Galpha(s) and Galpha(q). J. Biol. Chem. 275 (2000) 1327-1336
80. Fishburn C.S., Pollitt S.K., and Bourne H.R. Localization of a peripheral membrane protein: Gbetagamma targets Galpha(Z). Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1085-1090
81. Gonzalo S., and Linder M.E. SNAP-25 palmitoylation and plasma membrane targeting require a functional secretory pathway. Mol. Biol. Cell 9 (1998) 585-597
82. Fishburn C.S., Herzmark P., Morales J., and Bourne H.R. Gbetagamma and palmitate target newly synthesized Galphaz to the plasma membrane. J. Biol. Chem. 274 (1999) 18793-18800
83. Deshmukh D.S., Vorbrodt A.W., Lee P.K., Bear W.D., and Kuizon S. Studies on the submicrosomal fractions of bovine oligodendroglia: lipid composition and glycolipid biosynthesis. Neurochem. Res. 13 (1988) 571-582
84. van Helvoort A., and van Meer G. Intracellular lipid heterogeneity caused by topology of synthesis and specificity in transport. Example: sphingolipids. FEBS Lett. 369 (1995) 18-21
85. Verkleij A.J., Zwaal R.F., Roelofsen B., Comfurius P., Kastelijn D., and van Deenen L.L. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta 323 (1973) 178-193
86. Bloj B., and Zilversmit D.B. Asymmetry and transposition rates of phosphatidylcholine in rat erythrocyte ghosts. Biochemistry 15 (1976) 1277-1283
87. Rothman J.E., and Lenard J. Membrane asymmetry. Science 195 (1977) 743-753
88. Simons K., and Vaz W.L. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 269-295
89. Nichols B.J., Kenworthy A.K., Polishchuk R.S., Lodge R., Roberts T.H., Hirschberg K., Phair R.D., and Lippincott-Schwartz J. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153 (2001) 529-541
90. Vereb G., Szollosi J., Matko J., Nagy P., Farkas T., Vigh L., Matyus L., Waldmann T.A., and Damjanovich S. Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8053-8058
91. Singer S.J., and Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 175 (1972) 720-731
92. Yeagle P. The Structure of Biological Membranes (2005), CRC Press
93. Brown D.A., and London E. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes?. Biochem. Biophys. Res. Commun. 240 (1997) 1-7
94. Aussenac F., Tavares M., and Dufourc E.J. Cholesterol dynamics in membranes of raft composition: a molecular point of view from 2H and 31P solid-state NMR. Biochemistry 42 (2003) 1383-1390
95. Kinnunen P.K.J. On the molecular-level mechanisms of peripheral protein-membrane interactions induced by lipids forming inverted non-lamellar phases. Chem. Phys. Lipids Prop. Biol. Roles Non-Lamellar Forming Lipids 81 (1996) 151-166
96. Wilschut J. In: Hoekstra J.W.D. (Ed). Membrane Fusion (1990), Dekker, Groningen 89-126
97. Emoto K., Kobayashi T., Yamaji A., Aizawa H., Yahara I., Inoue K., and Umeda M. Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12867-12872
98. Vessey D.A., and Zakim D. Membrane fluidity and the regulation of membrane-bound enzymes. Horiz. Biochem. Biophys. 1 (1974) 138-174
99. Chapman D., and Quinn P.J. A method for the modulation of membrane fluidity: homogeneous catalytic hydrogenation of phospholipids and phospholipids and phospholipid-water model biomembranes. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 3971-3975
100. Goebel K.M., and Schneider J. Erythrocyte membrane fluidity, lipid peroxidation and lysis in alcoholic liver disease. Acta Biol. Med. Ger. 40 (1981) 571-576
101. Berlin E., Matusik Jr. E.J., and Young Jr. C. Effect of dietary fat on the fluidity of platelet membranes. Lipids 15 (1980) 604-608
102. van Rensburg S.J., Carstens M.E., Potocnik F.C., Aucamp A.K., Taljaard J.J., and Koch K.R. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes. Neurochem. Res. 17 (1992) 825-829
103. Roth G.S., Joseph J.A., and Mason R.P. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci. 18 (1995) 203-206
104. Wells K., Farooqui A.A., Liss L., and Horrocks L.A. Neural membrane phospholipids in Alzheimer disease. Neurochem. Res. 20 (1995) 1329-1333
105. Zicha J., Kunes J., and Devynck M.A. Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am. J. Hypertens. 12 (1999) 315-331
106. Tsuda K., Tsuda S., Minatogawa Y., Iwahashi H., Kido R., and Masuyama Y. Decreased membrane fluidity of erythrocytes and cultured vascular smooth muscle cells in spontaneously hypertensive rats: an electron spin resonance study. Clin. Sci. (Lond.) 75 (1988) 477-480
107. Tsuda K., Tsuda S., Minatogawa Y., Iwahashi H., Shima H., Yoshikawa H., Ura M., Takeda J., Kimura K., Nishio I., et al. Membrane fluidity of erythrocytes and its relevance to renin profile in essential hypertension. Jpn. Circ. J. 52 (1988) 1301-1308
108. Dominiczak A.F., McLaren Y., Kusel J.R., Ball D.L., Goodfriend T.L., Bohr D.F., and Reid J.L. Lateral diffusion and fatty acid composition in vascular smooth muscle membrane from stroke-prone spontaneously hypertensive rats. Am. J. Hypertens 6 (1993) 1003-1008
109. Gurdal H., Friedman E., and Johnson M.D. Beta-adrenoceptor-G alpha S coupling decreases with age in rat aorta. Mol. Pharmacol. 47 (1995) 772-778
110. Fraeyman N., Vanscheeuwijck P., De Wolf M., and Quatacker J. Influence of aging on fluidity and coupling between beta-receptors and G-proteins in rat lung membranes. Life Sci. 53 (1993) 153-160
111. Neubig R.R., Gantzos R.D., and Thomsen W.J. Mechanism of agonist and antagonist binding to alpha 2 adrenergic receptors: evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry 27 (1988) 2374-2384
112. Yang S., Zhang L., and Huang Y. Membrane association and conformational change of palmitoylated G(o)alpha. FEBS Lett. 498 (2001) 76-81
113. Basanez G., Nieva J.L., Goni F.M., and Alonso A. Origin of the lag period in the phospholipase C cleavage of phospholipids in membranes. Concomitant vesicle aggregation and enzyme activation. Biochemistry 35 (1996) 15183-15187
114. Cullis P.R., and Hope M.J. In: Vance D.E., and Vance J. (Eds). Biochemistry of Lipids, Lipoproteins, and Membranes (1991), Elsevier Science Publishers B.V, Amsterdam 1-41
115. Perkins W.R., Dause R.B., Parente R.A., Minchey S.R., Neuman K.C., Gruner S.M., Taraschi T.F., and Janoff A.S. Role of lipid polymorphism in pulmonary surfactant. Science 273 (1996) 330-332
116. Vogler O., Casas J., Capo D., Nagy T., Borchert G., Martorell G., and Escriba P.V. The Gbetagamma dimer drives the interaction of heterotrimeric Gi proteins with nonlamellar membrane structures. J. Biol. Chem. 279 (2004) 36540-36545
117. Escriba P.V., Sastre M., and Garcia-Sevilla J.A. Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7595-7599
118. Botelho A.V., Gibson N.J., Thurmond R.L., Wang Y., and Brown M.F. Conformational energetics of rhodopsin modulated by nonlamellar-forming lipids. Biochemistry 41 (2002) 6354-6368
119. Alves I.D., Salgado G.F., Salamon Z., Brown M.F., Tollin G., and Hruby V.J. Phosphatidylethanolamine enhances rhodopsin photoactivation and transducin binding in a solid supported lipid bilayer as determined using plasmon-waveguide resonance spectroscopy. Biophys. J. 88 (2005) 198-210
120. Feller S.E., and Gawrisch K. Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin. Curr. Opin. Struct. Biol. 15 (2005) 416-422
121. van der Wel P.C., Pott T., Morein S., Greathouse D.V., Koeppe II R.E., and Killian J.A. Tryptophan-anchored transmembrane peptides promote formation of nonlamellar phases in phosphatidylethanolamine model membranes in a mismatch-dependent manner. Biochemistry 39 (2000) 3124-3133
122. Hessel E., Muller P., Herrmann A., and Hofmann K.P. Light-induced reorganization of phospholipids in rod disc membranes. J. Biol. Chem. 276 (2001) 2538-2543
123. Oh P., and Schnitzer J.E. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12 (2001) 685-698
124. Huang C., Hepler J.R., Chen L.T., Gilman A.G., Anderson R.G., and Mumby S.M. Organization of G proteins and adenylyl cyclase at the plasma membrane. Mol. Biol. Cell 8 (1997) 2365-2378
125. Nair K.S., Balasubramanian N., and Slepak V.Z. Signal-dependent translocation of transducin, RGS9-1-Gbeta5L complex, and arrestin to detergent-resistant membrane rafts in photoreceptors. Curr. Biol. 12 (2002) 421-425
126. Oshikawa J., Toya Y., Fujita T., Egawa M., Kawabe J., Umemura S., and Ishikawa Y. Nicotinic acetylcholine receptor alpha 7 regulates cAMP signal within lipid rafts. Am. J. Physiol.: Cell Physiol. 285 (2003) C567-C574
127. Smart E.J., Ying Y.S., and Anderson R.G. Hormonal regulation of caveolae internalization. J. Cell Biol. 131 (1995) 929-938
128. Melkonian K.A., Ostermeyer A.G., Chen J.Z., Roth M.G., and Brown D.A. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274 (1999) 3910-3917
129. Moffett S., Brown D.A., and Linder M.E. Lipid-dependent targeting of G proteins into rafts. J. Biol. Chem. 275 (2000) 2191-2198
130. Funari S.S., Prades J., Escriba P.V., and Barcelo F. Farnesol and geranylgeraniol modulate the structural properties of phosphatidylethanolamine model membranes. Mol. Membr. Biol. 22 (2005) 303-311
131. DebBurman S.K., Ptasienski J., Boetticher E., Lomasney J.W., Benovic J.L., and Hosey M.M. Lipid-mediated regulation of G protein-coupled receptor kinases 2 and 3. J. Biol. Chem. 270 (1995) 5742-5747
132. Inglese J., Koch W.J., Caron M.G., and Lefkowitz R.J. Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases. Nature 359 (1992) 147-150
133. Premont R.T., Macrae A.D., Stoffel R.H., Chung N., Pitcher J.A., Ambrose C., Inglese J., MacDonald M.E., and Lefkowitz R.J. Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J. Biol. Chem. 271 (1996) 6403-6410
134. Goni F.M. Non-permanent proteins in membranes: when proteins come as visitors (Review). Mol. Membr. Biol. 19 (2002) 237-245
135. Heinz D.W., Ryan M., Bullock T.L., and Griffith O.H. Crystal structure of the phosphatidylinositol-specific phospholipase C from Bacillus cereus in complex with myo-inositol. EMBO J. 14 (1995) 3855-3863
136. Hondal R.J., Zhao Z., Kravchuk A.V., Liao H., Riddle S.R., Yue X., Bruzik K.S., and Tsai M.D. Mechanism of phosphatidylinositol-specific phospholipase C: a unified view of the mechanism of catalysis. Biochemistry 37 (1998) 4568-4580
137. Ryan M., Liu T., Dahlquist F.W., and Griffith O.H. A catalytic diad involved in substrate-assisted catalysis: NMR study of hydrogen bonding and dynamics at the active site of phosphatidylinositol-specific phospholipase C. Biochemistry 40 (2001) 9743-9750
138. Kubiak R.J., Yue X., Hondal R.J., Mihai C., Tsai M.D., and Bruzik K.S. Involvement of the Arg-Asp-His catalytic triad in enzymatic cleavage of the phosphodiester bond. Biochemistry 40 (2001) 5422-5432
139. Wehbi H., Feng J., Kolbeck J., Ananthanarayanan B., Cho W., and Roberts M.F. Investigating the interfacial binding of bacterial phosphatidylinositol-specific phospholipase C. Biochemistry 42 (2003) 9374-9382
140. Wallace B.A., and Janes R.W. Tryptophans in membrane proteins. X-ray crystallographic analyses. Adv. Exp. Med. Biol. 467 (1999) 789-799
141. Stahelin R.V., and Cho W. Roles of calcium ions in the membrane binding of C2 domains. Biochem. J. 359 (2001) 679-685
142. Feng J., Wehbi H., and Roberts M.F. Role of tryptophan residues in interfacial binding of phosphatidylinositol-specific phospholipase C. J. Biol. Chem. 277 (2002) 19867-19875
143. Volwerk J.J., Filthuth E., Griffith O.H., and Jain M.K. Phosphatidylinositol-specific phospholipase C from Bacillus cereus at the lipid-water interface: interfacial binding, catalysis, and activation. Biochemistry 33 (1994) 3464-3474
144. Zhou C., Qian X., and Roberts M.F. Allosteric activation of phosphatidylinositol-specific phospholipase C: specific phospholipid binding anchors the enzyme to the interface. Biochemistry 36 (1997) 10089-10097
145. Qian X., Zhou C., and Roberts M.F. Phosphatidylcholine activation of bacterial phosphatidylinositol-specific phospholipase C toward PI vesicles. Biochemistry 37 (1998) 6513-6522
146. Zhang X., Wehbi H., and Roberts M.F. Cross-linking phosphatidylinositol-specific phospholipase C traps two activating phosphatidylcholine molecules on the enzyme. J. Biol. Chem. 279 (2004) 20490-20500
147. Berg O.G., Yu B.Z., Apitz-Castro R.J., and Jain M.K. Phosphatidylinositol-specific phospholipase C forms different complexes with monodisperse and micellar phosphatidylcholine. Biochemistry 43 (2004) 2080-2090
148. Ahyayauch H., Villar A.V., Alonso A., and Goni F.M. Modulation of PI-specific phospholipase C by membrane curvature and molecular order. Biochemistry 44 (2005) 11592-11600
149. Nieva J.L., Goni F.M., and Alonso A. Liposome fusion catalytically induced by phospholipase C. Biochemistry 28 (1989) 7364-7367
150. Villar A.V., Alonso A., and Goni F.M. Leaky vesicle fusion induced by phosphatidylinositol-specific phospholipase C: observation of mixing of vesicular inner monolayers. Biochemistry 39 (2000) 14012-14018
151. Villar A.V., Goni F.M., and Alonso A. Diacylglycerol effects on phosphatidylinositol-specific phospholipase C activity and vesicle fusion. FEBS Lett. 494 (2001) 117-120
152. Goni F.M., and Alonso A. Membrane fusion induced by phospholipase C and sphingomyelinases. Biosci. Rep. 20 (2000) 443-463
153. Haines K.A., Reibman J., Tang X.Y., Blake M., and Weissmann G. Effects of protein I of Neisseria gonorrhoeae on neutrophil activation: generation of diacylglycerol from phosphatidylcholine via a specific phospholipase C is associated with exocytosis. J. Cell Biol. 114 (1991) 433-442
154. Hodgkin M.N., Pettitt T.R., Martin A., Michell R.H., Pemberton A.J., and Wakelam M.J. Diacylglycerols and phosphatidates: which molecular species are intracellular messengers?. Trends Biochem. Sci. 23 (1998) 200-204
155. Roldan E.R., and Murase T. Polyphosphoinositide-derived diacylglycerol stimulates the hydrolysis of phosphatidylcholine by phospholipase C during exocytosis of the ram sperm acrosome. Effect is not mediated by protein kinase C. J. Biol. Chem. 269 (1994) 23583-23589
156. Spungin B., Margalit I., and Breitbart H. Sperm exocytosis reconstructed in a cell-free system: evidence for the involvement of phospholipase C and actin filaments in membrane fusion. J. Cell Sci. 108 Pt 6 (1995) 2525-2535
157. O'Toole C.M., Roldan E.R., Hampton P., and Fraser L.R. A role for diacylglycerol in human sperm acrosomal exocytosis. Mol. Hum. Reprod. 2 (1996) 317-326
158. 2+-dependent exocytosis in boar spermatozoa. Mol. Reprod. Dev. 48 (1997) 95-105
159. Jun Y., Fratti R.A., and Wickner W. Diacylglycerol and its formation by phospholipase C regulate Rab- and SNARE-dependent yeast vacuole fusion. J. Biol. Chem. 279 (2004) 53186-53195
160. Kearns B.G., McGee T.P., Mayinger P., Gedvilaite A., Phillips S.E., Kagiwada S., and Bankaitis V.A. Essential role for diacylglycerol in protein transport from the yeast Golgi complex. Nature 387 (1997) 101-105
161. Bard F., and Malhotra V. The formation of TGN-to-plasma-membrane transport carriers. Annu. Rev. Cell Dev. Biol. (2006) in press
162. Manzoli L., Martelli A.M., Billi A.M., Faenza I., Fiume R., and Cocco L. Nuclear phospholipase C: involvement in signal transduction. Prog. Lipid Res. 44 (2005) 185-206
163. Patterson R.L., van Rossum D.B., Nikolaidis N., Gill D.L., and Snyder S.H. Phospholipase C-gamma: diverse roles in receptor-mediated calcium signaling. Trends. Biochem. Sci. 30 (2005) 688-697
164. Kim Y.H., Park T.J., Lee Y.H., Baek K.J., Suh P.G., Ryu S.H., and Kim K.T. Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation. J. Biol. Chem. 274 (1999) 26127-26134
165. Schmidt M., Evellin S., Weernink P.A., von Dorp F., Rehmann H., Lomasney J.W., and Jakobs K.H. A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat. Cell Biol. 3 (2001) 1020-1024
166. 2+ oscillations in mouse eggs. J. Biol. Chem. 279 (2004) 10408-10412
167. Cockcroft S. The latest phospholipase C, PLCeta, is implicated in neuronal function. Trends Biochem. Sci. 31 (2006) 4-7
168. Rebecchi M.J., and Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80 (2000) 1291-1335
169. Meldrum E., Parker P.J., and Carozzi A. The PtdIns-PLC superfamily and signal transduction. Biochim. Biophys. Acta 1092 (1991) 49-71
170. Apiyo D., Zhao L., Tsai M.D., and Selby T.L. X-ray structure of the R69D phosphatidylinositol-specific phospholipase C enzyme: insight into the role of calcium and surrounding amino acids in active site geometry and catalysis. Biochemistry 44 (2005) 9980-9989
171. Bottomley M.J., Salim K., and Panayotou G. Phospholipid-binding protein domains. Biochim. Biophys. Acta 1436 (1998) 165-183
172. Hirata M., Kanematsu T., Takeuchi H., and Yagisawa H. Pleckstrin homology domain as an inositol compound binding module. Jpn. J. Pharmacol. 76 (1998) 255-263
173. Lemmon M.A., and Ferguson K.M. Pleckstrin homology domains. Curr. Top Microbiol. Immunol. 228 (1998) 39-74
174. Lemmon M.A., and Ferguson K.M. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350 Pt1 (2000) 1-18
175. Ferguson K.M., Lemmon M.A., Schlessinger J., and Sigler P.B. Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. Cell 83 (1995) 1037-1046
176. Tuzi S., Uekama N., Okada M., Yamaguchi S., Saito H., and Yagisawa H. Structure and dynamics of the phospholipase C-delta1 pleckstrin homology domain located at the lipid bilayer surface. J. Biol. Chem. 278 (2003) 28019-28025
177. Flesch F.M., Yu J.W., Lemmon M.A., and Burger K.N. Membrane activity of the phospholipase C-delta1 pleckstrin homology (PH) domain. Biochem. J. 389 (2005) 435-441
178. Varnai P., Lin X., Lee S.B., Tuymetova G., Bondeva T., Spat A., Rhee S.G., Hajnoczky G., and Balla T. Inositol lipid binding and membrane localization of isolated pleckstrin homology (PH) domains. Studies on the PH domains of phospholipase C delta 1 and p130. J. Biol. Chem. 277 (2002) 27412-27422
179. Wang T., Pentyala S., Rebecchi M.J., and Scarlata S. Differential association of the pleckstrin homology domains of phospholipases C-beta 1, C-beta 2, and C-delta 1 with lipid bilayers and the beta gamma subunits of heterotrimeric G proteins. Biochemistry 38 (1999) 1517-1524
180. Singh S.M., and Murray D. Molecular modeling of the membrane targeting of phospholipase C pleckstrin homology domains. Protein Sci. 12 (2003) 1934-1953
181. Falasca M., Logan S.K., Lehto V.P., Baccante G., Lemmon M.A., and Schlessinger J. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17 (1998) 414-422
182. van Rossum D.B., Patterson R.L., Sharma S., Barrow R.K., Kornberg M., Gill D.L., and Snyder S.H. Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain. Nature 434 (2005) 99-104
183. Lemmon M.A. Pleckstrin homology domains: two halves make a hole?. Cell 120 (2005) 574-576
184. Kobayashi M., Mutharasan R.K., Feng J., Roberts M.F., and Lomasney J.W. Identification of hydrophobic interactions between proteins and lipids: free fatty acids activate phospholipase C delta1 via allosterism. Biochemistry 43 (2004) 7522-7533
185. Goni F.M., and Alonso A. Structure and functional properties of diacylglycerols in membranes. Prog. Lipid Res. 38 (1999) 1-48
186. Martinez J., Vogler O., Casas J., Barcelo F., Alemany R., Prades J., Nagy T., Baamonde C., Kasprzyk P.G., Teres S., Saus C., and Escriba P.V. Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval. Mol. Pharmacol. 67 (2005) 531-540
187. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9 (1995) 484-496
188. Bell R.M., and Burns D.J. Lipid activation of protein kinase C. J. Biol. Chem. 266 (1991) 4661-4664
189. Mosior M., Golini E.S., and Epand R.M. Chemical specificity and physical properties of the lipid bilayer in the regulation of protein kinase C by anionic phospholipids: evidence for the lack of a specific binding site for phosphatidylserine. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1907-1912
190. Hinderliter A.K., Dibble A.R., Biltonen R.L., and Sando J.J. Activation of protein kinase C by coexisting diacylglycerol-enriched and diacylglycerol-poor lipid domains. Biochemistry 36 (1997) 6141-6148
191. Zhang G., Kazanietz M.G., Blumberg P.M., and Hurley J.H. Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester. Cell 81 (1995) 917-924
192. Slater S.J., Kelly M.B., Taddeo F.J., Ho C., Rubin E., and Stubbs C.D. The modulation of protein kinase C activity by membrane lipid bilayer structure. J. Biol. Chem. 269 (1994) 4866-4871
193. Escriba P.V. Membrane-lipid therapy: a new approach in molecular medicine. Trends Mol. Med. 12 (2006) 34-43
194. Perona J.S., and Ruiz-Gutierrez V. Triacylglycerol molecular species are depleted to different extents in the myocardium of spontaneously hypertensive rats fed two oleic acid-rich oils. Am. J. Hypertens. 18 (2005) 72-80
195. Dey I., Buda C., Wiik T., Halver J.E., and Farkas T. Molecular and structural composition of phospholipid membranes in livers of marine and freshwater fish in relation to temperature. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7498-7502
196. Giorgione J., Epand R.M., Buda C., and Farkas T. Role of phospholipids containing docosahexaenoyl chains in modulating the activity of protein kinase C. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9767-9770
197. Martinez-Gonzalez M.A., and Sanchez-Villegas A. The emerging role of Mediterranean diets in cardiovascular epidemiology: monounsaturated fats, olive oil, red wine or the whole pattern?. Eur. J. Epidemiol. 19 (2004) 9-13
198. Bartoli R., Fernandez-Banares F., Navarro E., Castella E., Mane J., Alvarez M., Pastor C., Cabre E., and Gassull M.A. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 46 (2000) 191-199
199. Ruiz-Gutierrez V., Muriana F.J., Guerrero A., Cert A.M., and Villar J. Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J. Hypertens. 14 (1996) 1483-1490
200. de Wilde M.C., Hogyes E., Kiliaan A.J., Farkas T., Luiten P.G., and Farkas E. Dietary fatty acids alter blood pressure, behavior and brain membrane composition of hypertensive rats. Brain Res. 988 (2003) 9-19
201. Ovchinnikov Yu A., Abdulaev N.G., and Bogachuk A.S. Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated. FEBS Lett. 230 (1988) 1-5
202. Hayashi M.K., and Haga T. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. Arch. Biochem. Biophys. 340 (1997) 376-382
203. Hukovic N., Panetta R., Kumar U., Rocheville M., and Patel Y.C. The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. J. Biol. Chem. 273 (1998) 21416-21422
204. Horstmeyer A., Cramer H., Sauer T., Muller-Esterl W., and Schroeder C. Palmitoylation of endothelin receptor A. Differential modulation of signal transduction activity by post-translational modification. J. Biol. Chem. 271 (1996) 20811-20819
205. Stannard C., Lehenkari P., and Godovac-Zimmermann J. Functional diversity of endothelin pathways in human lung fibroblasts may be based on structural diversity of the endothelin receptors. Biochemistry 42 (2003) 13909-13918
206. Kawate N., and Menon K.M. Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells. Abolition of palmitoylation by mutation of Cys-621 and Cys-622 residues in the cytoplasmic tail increases ligand-induced internalization of the receptor. J. Biol. Chem. 269 (1994) 30651-30658
207. Jin H., Xie Z., George S.R., and O'Dowd B.F. Palmitoylation occurs at cysteine 347 and cysteine 351 of the dopamine D(1) receptor. Eur. J. Pharmacol. 386 (1999) 305-312
208. Tanaka K., Nagayama Y., Nishihara E., Namba H., Yamashita S., and Niwa M. Palmitoylation of human thyrotropin receptor: slower intracellular trafficking of the palmitoylation-defective mutant. Endocrinology 139 (1998) 803-806